MGC Pharmaceuticals (ASX:MXC) Share Price and News - StockTrack

Market Cap (29-Apr) $18,417,672 (949th)	Close (30-Jun) $0.005 0 (0%)	Volume (30-Jun) 14,697,042	Shortsold (2-Apr) 218 (0.00%) (630th)
52w High $9.00	52w Low $0.300	P/E 14.90	EPS -3.21

	Subject
	MXC MXC Ann: Application for quotation of securities - MXC
	1 (current) 2 3
	MXC MXC Ann: Notification regarding unquoted securities - MXC
	MXC MXC Ann: s708A(12C)(e) Cleansing Notice
	MXC MXC Ann: US$750,000 Convertible Note Facility Funding
	MXC MXC Ann: Proposed issue of securities - MXC
	MXC MXC Ann: AMC Holdings Inc places US$1 million ArtemiC order
	MXC MXC Ann: Study Results - Effects of CannEpil on driving performance
	MXC MXC Ann: Company Presentation (updated)
	MXC MXC Ann: Company Presentation
	MXC MXC Ann: s708A(5)(e) Cleansing Notice - Share Issue
	MXC MXC Ann: Application for quotation of securities - MXC
	MXC MXC Ann: Notification regarding unquoted securities - MXC
	MXC MXC Ann: s708A(5)(e) Cleansing Note
	MXC MXC Ann: Application for quotation of securities - MXC
	MXC MXC Ann: Application for quotation of securities - MXC
	MXC MXC Ann: Cleansing Notice - Convertible Securities
	MXC MXC Ann: US$1.2M Tranche 1 Funding Recevied from Mercer
	MXC MXC Ann: Proposed issue of securities - MXC
	MXC MXC Ann: Proposed issue of securities - MXC
	MXC MXC Ann: Cleansing Notice - Convertible Notes
	MXC MXC Ann: US$10M Financing Agreement signed with US Financier/Investor
	MXC MXC Ann: Proposed issue of securities - MXC
	MXC MXC Ann: Strategic Acquisition of 40% interest in ZAM Software Ltd
	MXC MXC Ann: Amended June Quarterly Reports (amended App. 4C)
	MXC MXC Ann: June Quarter Activities and Cash Flow Report
	MXC MXC Ann: Appointment of Chief Commercial Officer
	MXC MXC Ann: Long COVID Study Results for ArtemiC Support
	MXC MXC Ann: Approvals received for South African CimetrA Clinical Trial
	MXC MXC Ann: Launch of Medical Data Collection App - ZAM
	MXC MXC Ann: CimetrA anti-inflammatory pre-clinical study results
	MXC MXC Ann: US Market Update - CimetrA Clinical Trial Progress
	MXC MXC Ann: Glioblastoma pre-clinical trial results
	MXC MXC Ann: Cognicann Clinical Trial Results
	MXC MXC Ann: Response to ASX Aware Query
	MXC MXC Ann: s708A(5)(e) Cleansing Notice
	MXC MXC Ann: Application for quotation of securities - MXC
	MXC MXC Ann: Patent Granted for CannEpiL SNEDDS
	MXC MXC Ann: Change of Director's Interest Notice x 2
	MXC MXC Ann: March 2022 Quarterly Activity and Cash Flow Reports
	MXC MXC Ann: Appointment of London based CFO
	MXC MXC Ann: Patent Granted for CimetrA
	MXC MXC Ann: Change in directors' interests x 6 and cessation of CFO
	MXC MXC Ann: s708A(5)(e) Cleansing Notice
	MXC MXC Ann: Application for quotation of securities - MXC
	MXC MXC Ann: Notification of cessation of securities - MXC
	MXC MXC Ann: Notification of cessation of securities - MXC
	MXC MXC Ann: Sciensus Rare EU & UK Sales and Distribution Agreement
	MXC MXC Ann: Retirement of Joint Company Secretary
	MXC MXC Ann: Half Yearly Report and Accounts
	MXC MXC Ann: s708A(5)(e) Cleansing Notice

Similar Companies

Cann Group

CAN

Creso Pharma

CPH

Ecofibre

EOF

Incannex Healthcare

IHL

Medical Developments International

MVP

Mayne Pharma Group

MYX

Neuren Pharmaceuticals

NEU

Probiotec

PBP

Recce Pharmaceuticals Ltd

RCE

Starpharma Holdings

SPL

End of Day Prices

Date	Close	Volume	Change
29-Apr	$0.42	6,035	0.00 (0.00%)
26-Apr	$0.42	1,033	+0.01 (2.47%)
24-Apr	$0.41	6,603	-0.03 (5.81%)
23-Apr	$0.43	0	0.00 (0.00%)
22-Apr	$0.43	5,109	0.00 (0.00%)
19-Apr	$0.43	4,257	0.00 (0.00%)
18-Apr	$0.43	0	0.00 (0.00%)
17-Apr	$0.43	2	-0.01 (1.15%)
16-Apr	$0.44	18,828	-0.01 (2.25%)
15-Apr	$0.45	11,403	0.00 (0.00%)
12-Apr	$0.45	49,208	+0.01 (2.30%)
11-Apr	$0.44	8,542	+0.02 (4.82%)
10-Apr	$0.42	6,145	-0.02 (3.49%)
09-Apr	$0.43	43,411	+0.02 (3.61%)
08-Apr	$0.42	27,077	+0.01 (1.22%)
5 up, 4 down, and 6 flat days

High $0.01	Low $0.00	Trades 68	Turnover $72,477	Volume 14,697,042
30 June 2023 at 4:10pm

High $0.01	Low $0.00	Trades 68	Turnover $72,477	Volume 14,697,042
30 June 2023 at 4:10pm

MGC Pharmaceuticals Health Care

$0.005 (0%)

$0.005 (0%)

Followers

Prices

Announcements

Similar Companies

End of Day Prices